136 related articles for article (PubMed ID: 24772644)
1. [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
Smolonogina TA; Desheva IuA; Rekstin AR; Mironov AN; Rudenko LG
Vopr Virusol; 2013; 58(6):31-5. PubMed ID: 24772644
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
Rudenko L; Desheva J; Korovkin S; Mironov A; Rekstin A; Grigorieva E; Donina S; Gambaryan A; Katlinsky A
Influenza Other Respir Viruses; 2008 Nov; 2(6):203-9. PubMed ID: 19453396
[TBL] [Abstract][Full Text] [Related]
3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
4. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
5. Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness.
Chen PL; Hu AY; Lin CY; Weng TC; Lai CC; Tseng YF; Cheng MC; Chia MY; Lin WC; Yeh CT; Su IJ; Lee MS
Viruses; 2019 Jun; 11(6):. PubMed ID: 31212631
[TBL] [Abstract][Full Text] [Related]
6. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
[TBL] [Abstract][Full Text] [Related]
7. [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
Mazurkova NA; Ryndiuk NN; Shishkina LN; Ternovoĭ VA; Tumanov IuV; Bulychev LE; Skarnovich MO; Kabanov AS; Panchenko SG; Aleĭnikov RP; Il'ina TN; Kuzubov VI; Mel'nikov SIa; Mironov AN; Korovkin SA; Sergeev AN; Drozdov IG
Vestn Ross Akad Med Nauk; 2010; (3):15-20. PubMed ID: 20422755
[TBL] [Abstract][Full Text] [Related]
8. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
[TBL] [Abstract][Full Text] [Related]
9. [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
Sergeeva MV; Kuznetsov VV; Kas'ianenko MA; Shaldzhian AA; Repko IA; Potapchuk MV; Romanova IuR; Tsybalova LM
Vopr Virusol; 2013; 58(6):36-9. PubMed ID: 24772645
[TBL] [Abstract][Full Text] [Related]
10. Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.
Chirkova TV; Naykhin AN; Petukhova GD; Korenkov DA; Donina SA; Mironov AN; Rudenko LG
Clin Vaccine Immunol; 2011 Oct; 18(10):1710-8. PubMed ID: 21813657
[TBL] [Abstract][Full Text] [Related]
11. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
[TBL] [Abstract][Full Text] [Related]
12. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
[TBL] [Abstract][Full Text] [Related]
13. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
Rudenko L; Kiseleva I; Stukova M; Erofeeva M; Naykhin A; Donina S; Larionova N; Pisareva M; Krivitskaya V; Flores J;
Vaccine; 2015 Sep; 33(39):5110-7. PubMed ID: 26296497
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
15. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
16. [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].
Naĭkhin AN; Chirkova TV; Petukhova GD; Koren'kov DA; Donina SA; Rudenko LG
Vopr Virusol; 2012; 57(1):38-42. PubMed ID: 22624472
[TBL] [Abstract][Full Text] [Related]
17. Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.
Wang M; Wei Y; Pu J; Bing G; Sun Y; Sun H; Wei F; Liu J
Vet Microbiol; 2018 Jul; 220():57-66. PubMed ID: 29885802
[TBL] [Abstract][Full Text] [Related]
18. [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines].
Donina SA; Petukhova GD; Koren'kov DA; Grigor'eva EP; Kuznetsova SA; Losev IV; Rudenko LG; Naĭkhin AN
Vopr Virusol; 2013; 58(3):37-42. PubMed ID: 24006632
[TBL] [Abstract][Full Text] [Related]
19. [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
Boravleva EIu; Lomakina NF; Kropotkina EA; Rudneva IA; Iamnikova SS; Rudenko LG; Drygin VV; Gambarian AS
Vopr Virusol; 2011; 56(6):9-14. PubMed ID: 22359942
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
Shcherbik S; Carney P; Pearce N; Stevens J; Dugan VG; Wentworth DE; Bousse T
Virology; 2018 Sep; 522():65-72. PubMed ID: 30014859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
